Blue Shield of California Slashes Cost of Humira, World’s Best-Selling Drug.

Blue Shield of California will now use an FDA approved biosimilar of Humira at a quarter of the price. Humira has helped many patients treat inflammatory diseases, like arthritis, Crohn's disease, ulcerative colitis, psoriasis and more. This cut in price will provide relief for some of the 300,000 Americans that use Humira each year.

Read the full article below:

https://news.blueshieldca.com/2024/10/01/blue-shield-of-california-slashes-cost-of-worlds-best-selling-drug#:~:text=(October%201%2C%202024)%20%E2%80%93,price%20of%20Humira%20at%20%242%2C100.